Ressources
Versions internet et traduction
Ce manuel est sous copyright Creative Commons et il est disponible gratuitement sous forme de fichier téléchargeable en ligne ou de prêt-à-imprimer. Vous avez par avance la permission d’imprimer, copier, partager, mettre en lien, et distribuer autant de copies que vous le souhaitez. Disponible en traduction espagnole, allemande, grecque et française.
Ressources essentielles
MIND “Making Sense of Coming Off Psychiatric Drugs”
http://bit.ly/yPjusy
Recherches récentes pour la compréhension de la Maladie Mentale et des Expériences Psychotiques.
Département de Psychologie Clinique de la Société Britannique de Psychologie. www.bps.org.uk www.freedom-center.org/pdf/
britishpsychologicalsocietyrecentadvances.pdf
Coming Off Psychiatric Drugs: Successful Withdrawal from Neuroleptics, Antidepressants, Lithium, Carbamazepine and Tranquilizers
Peter Lehmann, ed.
www.peter-lehmann-publishing.com
Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America
par Robert Whitaker, Crown Books 2010.
Le site internet Beyond Meds
www.beyondmeds.com
| “Addressing non-adherence to antipsychotic medication:
a harm-reduction approach”
par Matthew Aldridge, Journal of Psychiatric Mental Health Nursing, Feb, 2012
http://bit.ly/wbUA6A
Coming Off Psychiatric Drugs: A Harm Reduction Approach - video avec Will Hall
http://bit.ly/zAMTRF
Psychiatric Drug Withdrawal : A Guide for Prescribers, Therapists, Patients and their Families
Par Peter Breggin, Springer Publishing, 2012.
Soutiens pour décrocher des médicaments
Thérapie Alternatives pour les Bipolaires
http://health.groups.yahoo.com/group/ALT-therapies4bipolar/
Antidepressant Solution: A Step-By Step guide to Safely Overcoming Antidepressant Withdrawal, Dependence, and ‘Addiction’
par Joseph Glenmullen Free Press, 2006
Benzo Buddies
www.benzobuddies.org
Benzodiazepines: Coopération et Non Confrontation
www.bcnc.org.uk
Benzodiazepenes: How They Work and How To Withdraw (The Ashton Manual)
par C. Heather Ashton
Benzo.org
www.benzo.org.uk
Forum de Sevrage de la benzo
http://benzowithdrawal.com/forum/
Benzo-Wise: A Recovery Companion
Baylissa Frederick 2009, Campanile Publishing
|
Etudes scientifiques
“Are Bad Sleeping Habits Driving Us Mad?” Emma Young, New Scientist, 18 February 2009
“Are Schizophrenia Drugs Always Needed?” Benedict Carey, The New York Times, March 21, 2006
www.freedom-center.org/pdf/
NYT3-21-06AreSchizophreniaDrugsAlwaysNeeded.pdf
“Atypical Antipsychotics in the Treatment of Schizophrenia: Systematic Overview and Meta-regression Analysis” John Geddes, et al.,British Medical Journal. 2000; 321:1371-1376 (2 December). Cited in “Leading Drugs for Psychosis Come Under New Scrutiny” Erica Goode, The New York Times, May 20, 2003
“Illness Risk Following Rapid Versus Gradual Discontinuation of Antidepressants” RJ Baldessarini, American Journal of Psychiatry, 167:934–941, 2010
“Effects of the Rate of Discontinuing Lithium Maintenance Treatment in Bipolar Disorders” RJ Baldessarini, Journal of Clinical Psychiatry 57:441-8, 1996
“The Diagnosis and Management of Benzodiazepine
Dependence” Heather Ashton, Current Opinion in Psychiatry 18(3):249-255, May 2005 | “Brain Volume Changes After Withdrawal of Atypical Antipsychotics in Patients with First-episode Schizophrenia” G. Boonstra, et al., J Clin Psychopharmacol. Apr;31(2):146-53 2011
“The Case Against Antipsychotic Drugs: a 50 Year Record of Doing More Harm Than Good” Robert Whitaker, Med Hypotheses. 62: 5-13 2004
“Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications.” J. Read, et al., Acta Psychiatr Scand 2005
Drug-Induced Dementia: A Perfect Crime
Grace E. Jackson MD, AuthorHouse 2009
“The Emperor’s New Drugs: An Analysis of Antidepressant Medication Data Submitted to the U.S. Food and Drug Administration” by Irving Kirsch, et. al.. Prevention & Treatment. July; 5(1) 2002
“Is Active Psychosis Neurotoxic?” T. H. McGlashan Schizophrenia Bulletin vol. 32 no. 2006
“Factors Involved in Outcome and Recovery in Schizophrenia Patients Not on Antipsychotic Medications: A 15-Year Multifollow-Up Study” Martin Harrow and Thomas H. Jobe, Journal of Nervous & Mental Disease. 195(5):406-414 May 2007
http://psychrights.org/Research/Digest/NLPs/
OutcomeFactors.pdf
|
“Empirical correction of seven myths about schizophrenia with implications for treatment.” C. Harding Acta Psychiatrica Scandinavica 384, suppl., 14-16, 1994
http://psychrights.org/research/Digest/Chronicity/myths.pdf
“The Vermont longitudinal study of persons with severe mental illness, I. Methodology, study sample, and overall status 32 years later.” C.M. Harding, et al. American Journal of Psychiatry. 144: 718-28., 1987
“Initiation and Adaptation: a Paradigm for Understanding Psychotropic Drug Action” SE Hyman and EJ Nestler Am J Psychiatry,153:151-162, 1996
“Is it Prozac, Or Placebo?“ by Gary Greenberg
Mother Jones. 2003; http://bit.ly/MDUbQl
“The Latest Mania: Selling Bipolar Disorder” David Healy PLoS Medicine. Vol. 3, No. 4, e185
“Long-term Antipsychotic Treatment and Brain Volumes” Beng-Choon Ho, et al. Arch Gen Psychiatry. 68, 2011
“Long-Term Follow-Up Studies of Schizophrenia”
by Brian Koehler
http://isps-us.org/koehler/longterm_followup.htm
MIND Coping With Coming Off Study
www.mind.org.uk/NR/rdonlyres/BF6D3FC0-4866-43B5-8BCA-B3EE10202326/3331/CWCOreportweb.pdf
or http://snipurl.com/MINDComingOffStudy
“Rethinking Models of Psychotropic Drug Action” J. Moncreiff and D.Cohen, Psychotherapy and Psychosomatics 74:145-153, 2005
The Myth of the Chemical Cure
Joanna Moncrieff, Palgrave Macmillan, 2008.
“Needed: Critical Thinking About Psychiatric
Medications” David Cohen, Ph.D www.ahrp.org/about/CohenPsychMed0504.pdf | “Gradual, 10% Dose Reductions Dramatically Reduce Antidepressant Discontinuation Symptoms: Presentation at the Canadian Psychiatric Association”Alison Palkhivala, Nov. 2007 http://www.docguide.com/gradual-10-dose-reductions-dramatically-reduce-antidepressant-discontinuation-symptoms-presented-cpa
“Paper In New ‘Psychosis’ Journal Shows Many Patients Do Better Without Psychiatric Drugs” Medical News Today Mar 2009
“Physical Illness Manifesting as Psychiatric Disease. Analysis of a State Hospital Inpatient Population” Hall RC, et. al. Arch Gen Psychiatry. Sep;37(9):989-95. 1980
“Predictors of Antipsychotic Withdrawal or Dose Reduction in a Randomized Controlled Trial of Provider Education” Meador KG, J Am Geriatr Soc. Feb;45(2):207-10. 1997
“Prevalence of Celiac Disease and Gluten Sensitivity in the United States Clinical Antipsychotic Trials of Intervention Effectiveness Study Population”
Nicola G. Cascella. et al. Schizophr Bull doi: 10.1093/schbul/sbp055 2009
Evelyn Pringle
www.opednews.com/author/author58.html
Psychiatric Drugs
Dr. Caligari, 1984
“Psychiatric Drugs as Agents of Trauma “ Charles L. Whitfield, The International Journal of Risk & Safety in Medicine 22 (2010)
“Psychiatric Drug Promotion and the Politics of Neoliberalism” by Joanna Moncrieff
The British Journal of Psychiatry. 2006; 188: 301-302. doi: 10.1192/bjp.188.4.301
“Psychosocial Treatment, Antipsychotic Postponement, and Low-dose Medication Strategies in First Episode Psychosis” Bola, J. R., Lehtinen, K., Cullberg, J., & Ciompi, L. (2009) Psychosis: Psychological, social and integrative approaches, 1(1), 4-18
|
“Are There Schizophrenics for Whom Drugs May be Unnecessary or Contraindicated?” M. Rappaport,
International Pharmacopsychiatry 13, 100-11, 1978
“Prejudice and Schizophrenia: a Review of the “Mental Illness is an Illness Like Any Other” Approach” Read, John el al. www.vermontrecovery.com/files/Download/foramanda.pdf
Rethinking Psychiatric Drugs: A Guide for Informed Consent
Grace Jackson AuthorHouse Publishing, 2009
“Review of The First Episode of Psychosis: A Guide for Patients and Their Families” by Compton, M.T. and Broussard, B. (2009, Oxford University Press). Best Practices in Mental Health: An International Journal , 6(2), 138-142. Bola, J. R. & Hall, W. (2010)
“Five-year experience of first-episode nonaffective psychosis in open-dialogue approach: Treatment principles, follow-up outcomes, and two case studies” Seikkula, J, Psychotherapy Research 16(2): 214-228, 2006
“Schizophrenia, Neuroleptic Medication, and Mortality” Joumkaa, M., et. al(2006) British Journal of Psychiatry, 188, 122-127, http://bit.ly/KIGxyu
“Serotonin and Depression: A Disconnect between
the Advertisements and the Scientific Literature” J.R. Lacasse and J. Leo PLoS Med. 2005; 2(12): e392 doi:10.1371/journal.pmed.0020392
“Soteria and Other Alternatives to Acute Psychiatric Hospitalization: A Personal and Professional Review”
Loren Mosher Journal of Nervous and Mental Disease. 1999; 187:142-149
“Pay Attention: Ritalin Acts Much Like Cocaine” Vastag, B. 2001. Journal of American Medical Association, 286, 905-906
“Clinical Risk Following Abrupt and Gradual
Withdrawal of Maintenance Neuroleptic Treatment” Viguera, AC, Arch Gen Psych.54:49-55, 1997
| “Withdrawal Syndromes Associated with Antipsychotic Drugs” G Gardos, et al. Am J Psychiatry 1978; 135
|
Les professionnels de la santé qui nous ont conseillésBien qu’illes ne soient pas co-auteurs, les professionnel(le)s de santé suivant sont expérimenté(e)s dans l’aide aux personnes désirant décrocher des médicaments psychotropes. Ils ont examiné ce guide, et nous les remercions pour leur implication :
Ed Altwies PsyD
David Anick MD, PhD
Marino Center for Integrative Health
Ron Bassman, PhD
Author, A Fight To Be: A Psychologist’s Experience from Both Sides of the Locked Door
Alexander Bingham, PsyD
Patrick Bracken, MD
Co-author, Post-Psychiatry, Mental Health in a Postmodern World
Christopher Camilleri, MD
Los Angeles County Department of Mental Health
Michael Cornwall, PhD
David Cohen, PhD
Co-author, Your Drug May Be Your Problem
Celine Cyr
Gaining Autonomy with Medication
Patricia Deegan, PhD
CommonGround
Jacqui Dillon
Hearing Voices Network UK
Kelley Eden, MS, ND
Neil Falk, MD
Cascadia Behavioral Healthcare
Daniel Fisher, MD
National Empowerment Center
Mark Foster, MD
Clear Minds
Chris Gordon, MD
Massachusetts General Hospital
Jen Gouvea, PhD, MSW
Engaged Heart Flower Essences
Mark Green MD
Westbridge Community Service
Nazlim Hagmann, MD
Lee Hurter
NADA Certified Acupuncturist
Gianna Kali
Publisher, Beyond Meds website
Peter Lehmann
Editor, Coming off Psychiatric Drugs: Successful Withdrawal from Neuroleptics, Antidepressants, Lithium, Carbamazepine and Tranquilizers
Bruce Levine, PhD
Author, Surviving America’s Depression Epidemic: How to Find Morale, Energy, and Community in a World Gone Crazy
Bradley Lewis, MD, PhD
Author, Narrative Psychiatry
Krista Mackinnon
Practice Recovery
Daniel Mackler, LCSW
Director, Take These Broken Wings
|
Rufus May, Dclin
Evolving Minds Bradford, UK
Elissa Mendenhall, ND
Renee Mendez, RN
Windhorse Associates
Dawn Menken, PhD
Process Work Institute
Arnold Mindell, PhD
Author, ProcessMind: A User’s Guide to
Connecting with the Mind of God
Joanna Moncrieff, MD
Author, The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment
Pierre Morin, MD, PhD
Lutheran Community Services
Matthew Morrissey, MFT
Co-Editor, Way Out Of Madness: Dealing
With Your Family After You’ve Been Diagnosed
With A Psychiatric Disorder
Sharna Olfman, PhD
Author, Bipolar Children: Cutting-Edge Controversy, Insights, and Research
Catherine Penney, RN
Dante’s Cure: A Journey Out of Madness
Judith E. Pentz, MD
Maxine Radcliffe, RN
Action Medics
Myriam Rahman, MA, DiplPW
Process Work Institute
Lloyd Ross, PhD
Judith Schreiber, LCSW
Soteria Associates
Michael Smith, MD, Licensed Acupuncturist
National Acupuncture Detoxification Association
Susan Smith, Intrinsic Coach
Proactive Planning
Claudia Sperber, Licensed Acupuncturist
Linda Star Wolf
Venus Rising Association for Transformation
Peter Stastny, MD
International Network Towards
Alternatives for Recovery
Sandra Steingard, MD
Ted Sundlin, MD
Jefferson Behavioral Health
Philip Thomas, MD
Co-author, Post-Psychiatry, Mental Health in a Postmodern World
Krista Tricarico, ND
Toby Watson, PsyD
Associated Psychological Health Services
Barbara Weinberg, RN, Licensed Acupuncturist
Charles Whitfield, MD
Author, Not Crazy: You May Not Be Mentally Ill
Damon Williams, RN, PMHNP-BC
Laughing Heart LLC
Paris Williams, PhD
Author, Rethinking Madness: Towards a Paradigm Shift in Our Understanding and Treatment of Psychosis
|
|
Sommaire
I. Introduction
II. Réduction des effets nocifs
III. Nous sommes tous différents
IV. Regard critique sur les 'troubles mentaux' et la psychiatrie
V. Sevrage - introduction
VI. Psychotropes et cerveau
VII. Risques des psychotropes pour la santé
VIII. Effets du sevrage
IX. Avant de commencer un sevrage
X. Stratégies alternatives
XI. Etape par étape
XII. Considérations spéciales
XIII. Perspectives
Annexes : Bibliographie et remerciements
|
